Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 774

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

Open access
Astor, Brad C., the Chronic Kidney Disease Prognosis Consortium, Matsushita, Kunihiro, Gansevoort, Ron T., van der Velde, Marije, Woodward, Mark, Levey, Andrew S., Jong, Paul E. de, Coresh, Josef·2011·Kidney International

Abstract

Limited data are available on the independent associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality and end stage renal disease (ESRD) among individuals with chronic kidney disease (CKD). We conducted a collaborative meta-analysis of 21,688 participants selected for CKD from 13 cohorts. After adjustment for potential confounders and albuminuria, a 15 mL/min/1.73 m2 lower eGFR below 45 mL/min/1.73 m2 was significantly associated with mortality (pooled hazard ratio [HR] 1.47 [95% CI: 1.22–1.79]), and ESRD (pooled HR 6.24 [95% CI: 4.84–8.05]). There was significant heterogeneity between studies for both HR estimates. After adjustment for risk factors and eGFR, an eight-fold higher albumin:creatinine ratio (ACR) or protein:creatinine ratio (PCR) was significantly associated with mortality (pooled HR 1.40 [95% CI: 1.27–1.55]), without evidence of significant heterogeneity. An eight-fold higher ACR or PCR was also strongly associated with ESRD (pooled HR 3.04 [95% CI: 2.27–4.08]), with significant heterogeneity between HR estimates. Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD. The associations are stronger for ESRD than for mortality. The observed associations are consistent with CKD classification based on eGFR stages, and suggest that albuminuria provides additional prognostic information among individuals with CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ki.2010.550

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 16

  1. Eckardt, 2009, Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO, Am J Kidney Dis, 53, 915, 10.1053/j.ajkd.2009.04.001 · DOI · Paper page
  2. Menon, 2008, Long-term outcomes in nondiabetic chronic kidney disease, Kidney Int, 73, 1310, 10.1038/ki.2008.67 · DOI
  3. Wright, 2002, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial, JAMA, 288, 2421, 10.1001/jama.288.19.2421 · DOI · Paper page
  4. Levin, 2008, Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort, Am J Kidney Dis, 52, 661, 10.1053/j.ajkd.2008.06.023 · DOI · Paper page
  5. Landray, 2001, Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment, Am J Kidney Dis, 38, 537, 10.1053/ajkd.2001.26850 · DOI
  6. Johnson, 2007, Predicting renal replacement therapy and mortality in CKD, Am J Kidney Dis, 50, 559, 10.1053/j.ajkd.2007.07.006 · doi:10.1053/j.ajkd.2007.07.006
  7. Van Zuilen, 2008, MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients, J Nephrol, 21, 261
  8. Dieplinger, 2009, Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study, Kidney Int, 75, 408, 10.1038/ki.2008.560 · DOI
  9. Moranne, 2009, Timing of onset of CKD-related metabolic complications, J Am Soc Nephrol, 20, 164, 10.1681/ASN.2008020159 · DOI · Paper page
  10. Ruggenenti, 2001, ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy, J Am Soc Nephrol, 12, 2832, 10.1681/ASN.V12122832 · DOI · Paper page
  11. Ruggenenti, 2005, Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial, Lancet, 365, 939, 10.1016/S0140-6736(05)71082-5 · DOI · Paper page
  12. Hovind, 2004, Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study, BMJ, 328, 1105, 10.1136/bmj.38070.450891.FE · DOI · Paper page
  13. Clark, 2007, Reduced eGFR—does this mean CKD? (abstract), Nephrol Dial Transplant, 22, ix54
  14. National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1
  15. Levey, 2006, Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Intern Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004 · DOI · Paper page
  16. Clark, 2007, Reduced eGFR-does this mean CKD? (abstract), Nephrol Dial Transplant, 22, ix54

Cited by

See all 774

Metadata

Authors
Astor, B. C., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., Jong, P. E. D., & Coresh, J.
Venue
Kidney International
Publisher
Elsevier BV
Published
2011-06
Volume
79
Issue
12
Pages
1331-1340
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2126662750
Cited by
774
References
4
FWCI
7.63
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. https://app.cochat.ai/papers/10.1038/ki.2010.550
The paper
Astor, B. C., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., Jong, P. E. D., & Coresh, J. (2011). Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney International. https://doi.org/10.1038/ki.2010.550

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.